Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT03536793
Eligibility Criteria:
Inclusion Criteria:
General
* Capable of giving written informed consent
* Age ≥18 years
Pancreatic Cancer Cohort
\- Diagnosed with localised pancreatic cancer amenable to resection (distal pancreatectomy, total pancreatectomy or Whipple's procedure).
OR - Diagnosed with inoperable localised pancreatic cancer and referred for further management (malignant control subgroup).
Pancreatic Cysts Cohort
\- Presence of cystic lesions where MDT have agreed further diagnostic intervention procedures (including FNA/EUS) necessary.
OR - Patient the MDT have agreed have resectable lesions suspicious for pancreatic malignancy and going to surgery.
Benign Cohort
\- Referral for endoscopic cystogastrostomy for complicated acute pancreatitis characterised by peripancreatic fluid collections and pseudocysts in development or matured (non-resolving and requiring further intervention).
OR
* Referral for cholecystectomy for cholocystitis/chololethiasis. OR
* Patient planned to have endoscopy investigation for dyspepsia (normal control subgroup).
Exclusion Criteria:
General
* Inability to provide written informed consent
* Other known malignant condition, either active or in complete remission ≤5 years
* HIV, hepatitis C, or any other known communicable disease
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03536793
Study Brief:
Protocol Section:
NCT03536793